EVH earnings: real EPS beat/miss history, analyst consensus Buy, P/E -1.19. Updated 2026-07-23.
Evolent Health (EVH) Research Hub
Evolent Health (EVH) trades on NYSE, US in the Healthcare (Medical - Healthcare Information Services) sector. As of 2026-09-11, shares last closed at 4.19 USD (+0.96%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.19, market cap 0.63B. This hub links to the full technical, earnings and options research available for EVH.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Information Services) |
|---|---|
| Exchange | NYSE, US |
| Last close | 4.19 USD (+0.96%) |
| 52-week range | 2.95 USD – 6.21 USD |
| Trend regime | Range |
| 14-day RSI | 55 (Bullish) |
| Trailing P/E | -1.19 |
| Market cap | 0.63B |
| Dividend yield | 0.00% |
Available research for EVH
Covered Call on EVH: how it works, illustrative setup around the real 4.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EVH: how it works, illustrative setup around the real 4.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EVH: how it works, illustrative setup around the real 4.19 USD price, max profit/loss, breakeven and when to use it. Educational.
EVH technical analysis: range, last 4.19 USD, RSI 55, 52w range 2.95 USD–6.21 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is EVH in?
Evolent Health (EVH) is classified under Healthcare (Medical - Healthcare Information Services), listed on NYSE, US.
Is EVH in an uptrend or downtrend?
As of 2026-09-11, EVH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EVH's trailing P/E ratio?
EVH's trailing P/E is -1.19, with a market cap of 0.63B. See the earnings research page for full valuation detail.